Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/BRL-50481> ?p ?o }
Showing triples 1 to 66 of
66
with 100 triples per page.
- BRL-50481 abstract "BRL-50481 is a drug developed by GlaxoSmithKline which is the first compound that acts as a phosphodiesterase inhibitor selective for the PDE7 subtype. It has been shown to increase mineralisation activity in osteoblasts, suggesting a potential role for PDE7 inhibitors in the treatment of osteoporosis.".
- BRL-50481 casNumber "433695-36-4".
- BRL-50481 iupacName "N,N,2-Trimethyl-5-nitro-benzenesulfonamide".
- BRL-50481 pubchem "2921148".
- BRL-50481 thumbnail BRL50481_structure.png?width=300.
- BRL-50481 wikiPageID "20655304".
- BRL-50481 wikiPageLength "2905".
- BRL-50481 wikiPageOutDegree "8".
- BRL-50481 wikiPageRevisionID "667231481".
- BRL-50481 wikiPageWikiLink Category:Nitrobenzenes.
- BRL-50481 wikiPageWikiLink Category:Phosphodiesterase_inhibitors.
- BRL-50481 wikiPageWikiLink Category:Sulfonamides.
- BRL-50481 wikiPageWikiLink GlaxoSmithKline.
- BRL-50481 wikiPageWikiLink Osteoblast.
- BRL-50481 wikiPageWikiLink Osteoporosis.
- BRL-50481 wikiPageWikiLink PDE_inhibitor.
- BRL-50481 wikiPageWikiLink Phosphodiesterase_inhibitor.
- BRL-50481 wikiPageWikiLinkText "BRL-50481".
- BRL-50481 c "9".
- BRL-50481 casNumber "433695".
- BRL-50481 chembl "484928".
- BRL-50481 chemspiderid "2194720".
- BRL-50481 h "12".
- BRL-50481 hasPhotoCollection BRL-50481.
- BRL-50481 inchi "1".
- BRL-50481 inchikey "IFIUFCJFLGCQPH-UHFFFAOYAW".
- BRL-50481 iupacName "N,N,2-Trimethyl-5-nitro-benzenesulfonamide".
- BRL-50481 iupharLigand "5154".
- BRL-50481 molecularWeight "244.267".
- BRL-50481 n "2".
- BRL-50481 o "4".
- BRL-50481 pubchem "2921148".
- BRL-50481 s "1".
- BRL-50481 smiles "Cc1ccccc1SNC".
- BRL-50481 stdinchi "1".
- BRL-50481 stdinchikey "IFIUFCJFLGCQPH-UHFFFAOYSA-N".
- BRL-50481 verifiedfields "changed".
- BRL-50481 verifiedrevid "424658335".
- BRL-50481 watchedfields "changed".
- BRL-50481 wikiPageUsesTemplate Template:Drugbox.
- BRL-50481 wikiPageUsesTemplate Template:Phosphodiesterase_inhibitors.
- BRL-50481 subject Category:Nitrobenzenes.
- BRL-50481 subject Category:Phosphodiesterase_inhibitors.
- BRL-50481 subject Category:Sulfonamides.
- BRL-50481 hypernym Drug.
- BRL-50481 type Article.
- BRL-50481 type ChemicalSubstance.
- BRL-50481 type Drug.
- BRL-50481 type Amide.
- BRL-50481 type Article.
- BRL-50481 type Chemical.
- BRL-50481 type Inhibitor.
- BRL-50481 type Sulfonamide.
- BRL-50481 type ChemicalObject.
- BRL-50481 type Thing.
- BRL-50481 type Q8386.
- BRL-50481 comment "BRL-50481 is a drug developed by GlaxoSmithKline which is the first compound that acts as a phosphodiesterase inhibitor selective for the PDE7 subtype. It has been shown to increase mineralisation activity in osteoblasts, suggesting a potential role for PDE7 inhibitors in the treatment of osteoporosis.".
- BRL-50481 label "BRL-50481".
- BRL-50481 sameAs m.051x_7l.
- BRL-50481 sameAs BRL-50481.
- BRL-50481 sameAs BRL-50481.
- BRL-50481 sameAs Q4836375.
- BRL-50481 sameAs Q4836375.
- BRL-50481 wasDerivedFrom BRL-50481?oldid=667231481.
- BRL-50481 depiction BRL50481_structure.png.
- BRL-50481 isPrimaryTopicOf BRL-50481.